MARC RUBIN

Profile

First Name

: MARC

Middle Name

:

Last Name

: RUBIN

Related Companies
Titles
Company Name
Related People
DIRECTOR
SURFACE LOGIX INC
KEITH DIONNE, STEVEN GILLIS, WINSTON E. HENDERSON, DION MADSEN, W. JAMES O-SHEA, BRYAN ROBERTS, IVO STAIJEN, PAUL SWEETNAM, GEORGE WHITESIDES
EXECUTIVE OFFICER
INFORMOUS, INC.
BRIAN HIRSCH, LEN OSTROFF, C. BOWDOIN TRAIN
DIRECTOR
CURIS INC
SUSAN B. BAYH, MICHAEL P. GRAY, MARTYN D. GREENACRE, KENNETH I. KAITIN, ROBERT E. MARTELL, JAMES R. MCNAB, JR., MARK W. NOEL, DANIEL R. PASSERI, JAMES R. TOBIN, MAURIZIO VOI
EXECUTIVE OFFICER
CANVAS SOLUTIONS INC
MARK ANGELINO, JEAN-MARC EMDEN, NATE LENTZ, EDWARD MCCARTHY, CHRIS MORRISETTE, JAMES QUIGLEY, TED RIDGWAY, MATT TABRIZI, MARK WALSH
DIRECTOR
GEMMUS PHARMA INC.
CHRISTOPHER DUNN, DARYL FAULDS, WILLIAM GUILFORD, WILLIAM HOLSTEIN, LARRY MILLER
DIRECTOR
PATTISON COLE LLC
STEVEN BRAVERMAN, DREW HURNI, EVAN WEISFELD, STEVEN WEISFELD
EXECUTIVE OFFICER, DIRECTOR
TITAN PHARMACEUTICALS INC
JOSEPH A. AKERS, KATHERINE BEEBE, SUNIL BHONSLE, KATHERINE DEVARNEY, KATHERINE BEEBE DEVARNEY, DANE HALLBERG, RAJINDER A. KUMAR, M. DAVID MCFARLANE, JAMES R. MCNAB, JR., SCOTT A. SMITH
DIRECTOR
SORICIMED BIOPHARMA INC.
CAMILLE BELLIVEAU, ROBERT BRUCE, VAUGHN EMBRO-PANTELONY, PAUL GUNN, SUSAN HICKS, TOM REEVES, JACK STEWART
DIRECTOR
MEDICINE MAN TECHNOLOGIES, INC.
JONATHAN BERGER, JEFFREY COZAD, ROBERT DEGABRIELLE, PAUL DICKMAN, JUSTIN DYE, JEFFREY GARWOOD, CHARLES HAUPT, JOSHUA HAUPT, FORREST HOFFMASTER, NANCY HUBER, CHRISTINE JONES, NIRUP KRISHNAMURTHY, PAUL MONTALBANO, PRATAP MUKHARJI, DAN PABON, DANIEL PABON, JOSEPH P. PUGLISE, LEONARDO RIERA, BRETT ROPER, BRIAN RUDEN, JONATHAN SANDBERG, BRAD STEWART, BRADLEY STEWART, JAMES C. TORESON, JAMES S. TORESON, SALIM WAHDAN, WEI WANG, ANDREW WILLIAMS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-05
D
Link
OTHER 
SERVICES-MANAGEMENT CONSULTING SERVICES [8742] 
DECLINE TO DISCLOSE 
Equity 
2023-04-21 
2023-04-27
D
Link
OTHER 
SERVICES-MANAGEMENT CONSULTING SERVICES [8742] 
DECLINE TO DISCLOSE 
Equity 
2023-04-13 
2023-02-09
D
Link
OTHER 
SERVICES-MANAGEMENT CONSULTING SERVICES [8742] 
DECLINE TO DISCLOSE 
Equity 
2023-01-25 
2023-01-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
2022-02-07
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2022-02-04 
2022-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
2021-01-21
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2021-01-20 
2020-01-09
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2020-01-09 
2019-08-19
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2019-08-09 
2016-06-13
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-01 
2016-02-05
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-22 
2014-12-19
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-05 
2014-10-17
D/A
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-23 
2014-06-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-30 
2014-01-28
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-15 
2012-05-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2012-03-30 
2011-04-27
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-04-15 
2010-07-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-02